316 related articles for article (PubMed ID: 11123898)
1. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
Yakovlev S; Makogonenko E; Kurochkina N; Nieuwenhuizen W; Ingham K; Medved L
Biochemistry; 2000 Dec; 39(51):15730-41. PubMed ID: 11123898
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
[TBL] [Abstract][Full Text] [Related]
3. Conformational changes upon conversion of fibrinogen into fibrin. The mechanisms of exposure of cryptic sites.
Medved L; Tsurupa G; Yakovlev S
Ann N Y Acad Sci; 2001; 936():185-204. PubMed ID: 11460474
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of initiation of fibrinolysis by fibrin.
Medved L; Nieuwenhuizen W
Thromb Haemost; 2003 Mar; 89(3):409-19. PubMed ID: 12624622
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains.
Tsurupa G; Medved L
Biochemistry; 2001 Jan; 40(3):801-8. PubMed ID: 11170397
[TBL] [Abstract][Full Text] [Related]
6. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
Weitz JI; Leslie B; Ginsberg J
J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
Stewart RJ; Fredenburgh JC; Weitz JI
J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
[TBL] [Abstract][Full Text] [Related]
8. [PC-12 cells hydrolyze the fibrin clot by producing both plasminogen and its tissue activator].
Petrova IuI; Savchuk OM; Kalashnyk OM; Platonova TM; Skok MV; Cederholm-Williams S
Ukr Biokhim Zh (1999); 2004; 76(2):64-8. PubMed ID: 15915713
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.
Tsurupa G; Ho-Tin-Noé B; Anglés-Cano E; Medved L
J Biol Chem; 2003 Sep; 278(39):37154-9. PubMed ID: 12853452
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin].
Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL
Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069
[TBL] [Abstract][Full Text] [Related]
11. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site.
Makogonenko E; Tsurupa G; Ingham K; Medved L
Biochemistry; 2002 Jun; 41(25):7907-13. PubMed ID: 12069579
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
Wojta J; Beckmann R; Turcu L; Wagner OF; van Zonneveld AJ; Binder BR
J Biol Chem; 1989 May; 264(14):7957-61. PubMed ID: 2470738
[TBL] [Abstract][Full Text] [Related]
13. Fibrin-mediated plasminogen activation.
Nieuwenhuizen W
Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
Mosesson MW
Blood Coagul Fibrinolysis; 1997 Jul; 8(5):257-67. PubMed ID: 9282789
[TBL] [Abstract][Full Text] [Related]
15. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
Grinenko TV; Tret'iachenko VG; Kudinov SA; Medved' LV
Biokhimiia; 1987 Oct; 52(10):1732-9. PubMed ID: 3427134
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen fragments K 1-3 and K 5 bind to different sites in fibrin fragment DD.
Grinenko TV; Kapustianenko LG; Yatsenko TA; Yusova OI; Rybachuk VN
Ukr Biochem J; 2016; 88(3):36-45. PubMed ID: 29235323
[TBL] [Abstract][Full Text] [Related]
17. Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.
Tsurupa G; Yakovlev S; McKee P; Medved L
Biochemistry; 2010 Sep; 49(35):7643-51. PubMed ID: 20687529
[TBL] [Abstract][Full Text] [Related]
18. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator.
Fischer B
Biol Chem Hoppe Seyler; 1990 Nov; 371(11):1067-75. PubMed ID: 2128181
[TBL] [Abstract][Full Text] [Related]
20. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
Doolittle RF; Pandi L
Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]